Wrap (WRAP) 10-Q 9 Nov 22 2022 FY Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 09, 2022
Document Information [Line Items]
Entity Central Index Key	0001702924
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	000-55838
Entity Registrant Name	Wrap Technologies, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	98-0551945
Entity Address, Address Line One	1817 W 4th Street
Entity Address, City or Town	Tempe
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85281
City Area Code	800
Local Phone Number	583-2652
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	WRAP
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		41,124,312

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 3,828	$ 4,937
Short-term investments	19,865	29,983
Accounts receivable and contract assets	2,222	3,859
Inventories, net	2,962	1,566
Prepaid expenses and other current assets	600	868
Total current assets	29,477	41,213
Property and equipment, net	819	976
Operating lease right-of-use asset, net	311	51
Intangible assets, net	1,900	1,982
Other assets	11	9
Total assets	32,518	44,231
Current liabilities:
Accounts payable	945	1,779
Accrued liabilities	991	824
Customer deposits	0	43
Deferred revenue- short term	144	155
Operating lease liability - short term	106	56
Total current liabilities	2,186	2,857
Long-term liabilities:
Deferred revenue- long term	156	110
Operating lease liability - long term	221	0
Total long-term liabilities	377	110
Total liabilities	2,563	2,967
Commitments and contingencies
Stockholders' equity:
Preferred stock - 5,000,000 authorized; par value $0.0001 per share; none issued and outstanding	0	0
Common stock - 150,000,000 authorized; par value $0.0001 per share; 41,125,578 and 40,851,945 shares issued and outstanding each period, respectively	4	4
Additional paid-in capital	93,736	91,025
Accumulated deficit	(63,841)	(49,759)
Accumulated other comprehensive loss	56	(6)
Total stockholders' equity	29,955	41,264
Total liabilities and stockholders' equity	$ 32,518	$ 44,231

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited)-parentheticals (Parentheticals) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Preferred Stock, Shares Authorized (in shares)	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Issued (in shares)	0	0
Preferred Stock, Shares Outstanding, Ending Balance (in shares)	0	0
Common Stock, Shares Authorized (in shares)	150,000,000	150,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001	$ 0.0001
Common Stock, Shares, Issued (in shares)	41,125,578	40,851,945
Common Stock, Shares, Outstanding, Ending Balance (in shares)	41,125,578	40,851,945

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues:
Product sales	$ 1,612	$ 1,719	$ 4,042	$ 4,997
Other revenue	89	86	422	283
Total revenues	1,701	1,805	4,464	5,280
Cost of revenues:
Products and services	790	1,094	2,430	3,276
Product line exit expense	0	0	0	747
Total cost of revenues	790	1,094	2,430	4,023
Gross profit	911	711	2,034	1,257
Operating expenses:
Selling, general and administrative	3,586	4,654	11,952	16,210
Research and development	1,236	2,076	4,210	4,303
Total operating expenses	4,822	6,730	16,162	20,513
Loss from operations	(3,911)	(6,019)	(14,128)	(19,256)
Other income (expense):
Investment income	34	13	36	22
Other	12	15	10	14
Nonoperating Income (Expense), Total	46	28	46	36
Net loss	$ (3,865)	$ (5,991)	$ (14,082)	$ (19,220)
Net loss per basic and diluted common share (in dollars per share)	$ (0.09)	$ (0.15)	$ (0.34)	$ (0.50)
Weighted average common shares used to compute net loss per basic and diluted common share (in shares)	41,086,285	40,413,332	40,955,234	38,767,009
Comprehensive loss:
Net loss	$ (3,865)	$ (5,991)	$ (14,082)	$ (19,220)
Net unrealized gain (loss) on short-term investments	73	(2)	62	(4)
Comprehensive loss	$ (3,792)	$ (5,993)	$ (14,020)	$ (19,224)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member] Warrants at $6.50 Per Share [Member]	Common Stock [Member] Warrants at $8.125 Per Share [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Warrants at $6.50 Per Share [Member]	Additional Paid-in Capital [Member] Warrants at $8.125 Per Share [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member] Warrants at $6.50 Per Share [Member]	Retained Earnings [Member] Warrants at $8.125 Per Share [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member] Warrants at $6.50 Per Share [Member]	AOCI Attributable to Parent [Member] Warrants at $8.125 Per Share [Member]	AOCI Attributable to Parent [Member]	Warrants at $6.50 Per Share [Member]	Warrants at $8.125 Per Share [Member]	Total
Balance (in shares) at Dec. 31, 2020			37,554,162
Balance at Dec. 31, 2020			$ 4			$ 71,705			$ (25,310)			$ 15			$ 46,414
Common shares issued upon exercise of stock options (in shares)			915,404
Common shares issued upon exercise of stock options			$ 0			1,678			0			0			1,678
Share-based compensation expense			$ 0			4,310			0			0			4,310
Common shares issued upon vesting of restricted stock units (in shares)			421,407
Net unrealized gain (loss) on short-term investments			$ 0			0			0			(4)			(4)
Net loss			$ 0			0			(19,220)			0			(19,220)
Common shares issued upon exercise of warrants (in shares)	1,661,320	153,692
Common shares issued upon exercise of warrants	$ 0	$ 0		$ 10,799	$ 1,249		$ 0	$ 0		$ 0	$ 0		$ 10,799	$ 1,249
Common shares issued for services (in shares)			42,876
Common shares issued for services			$ 0			239			0			0			239
Balance (in shares) at Sep. 30, 2021			40,748,861
Balance at Sep. 30, 2021			$ 4			89,979			(44,530)			11			45,464
Balance (in shares) at Jun. 30, 2021			39,911,390
Balance at Jun. 30, 2021			$ 4			87,277			(38,539)			13			48,755
Common shares issued upon exercise of stock options (in shares)			758,338
Common shares issued upon exercise of stock options			$ 0			1,399			0			0			1,399
Share-based compensation expense			$ 0			1,303			0			0			1,303
Common shares issued upon vesting of restricted stock units (in shares)			79,133
Net unrealized gain (loss) on short-term investments			$ 0			0			0			(2)			(2)
Net loss			$ 0			0			(5,991)			0			(5,991)
Balance (in shares) at Sep. 30, 2021			40,748,861
Balance at Sep. 30, 2021			$ 4			89,979			(44,530)			11			45,464
Balance (in shares) at Dec. 31, 2021			40,851,945
Balance at Dec. 31, 2021			$ 4			91,025			(49,759)			(6)			$ 41,264
Common shares issued upon exercise of stock options (in shares)			55,500												55,500
Common shares issued upon exercise of stock options			$ 0			83			0			0			$ 83
Share-based compensation expense			$ 0			2,628			0			0			2,628
Common shares issued upon vesting of restricted stock units (in shares)			218,133
Net unrealized gain (loss) on short-term investments			$ 0			0			0			62			62
Net loss			$ 0			0			(14,082)			0			(14,082)
Balance (in shares) at Sep. 30, 2022			41,125,578
Balance at Sep. 30, 2022			$ 4			93,736			(63,841)			56			29,955
Balance (in shares) at Jun. 30, 2022			40,992,161
Balance at Jun. 30, 2022			$ 4			92,856			(59,976)			(17)			32,867
Common shares issued upon exercise of stock options (in shares)			5,500
Common shares issued upon exercise of stock options			$ 0			8			0			0			8
Share-based compensation expense			$ 0			872			0			0			872
Common shares issued upon vesting of restricted stock units (in shares)			127,917
Net unrealized gain (loss) on short-term investments			$ 0			0			0			73			73
Net loss			$ 0			0			(3,865)			0			(3,865)
Balance (in shares) at Sep. 30, 2022			41,125,578
Balance at Sep. 30, 2022			$ 4			$ 93,736			$ (63,841)			$ 56			$ 29,955

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Unaudited)-parentheticals (Parentheticals)	Sep. 30, 2021 $ / shares
Warrants at $6.50 Per Share [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 6.50
Warrants at $8.125 Per Share [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 8.125

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows From Operating Activities:
Net loss	$ (14,082)	$ (19,220)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	574	336
Product line exit expense	0	747
Gain on sale of assets	0	(17)
Warranty provision	55	23
Software impairment charge	0	170
Change in contingent liability	0	(23)
Non-cash lease expense	75	67
Share-based compensation	2,628	4,310
Common shares issued for services	0	239
Provision for doubtful accounts	61	27
Changes in assets and liabilities:
Accounts receivable	1,576	(1,414)
Inventories	(1,396)	(160)
Prepaid expenses and other current assets	268	231
Accounts payable	(834)	271
Operating lease liability	(65)	(71)
Customer deposits	(43)	19
Accrued liabilities and other	175	502
Warranty settlement	(63)	10
Deferred revenue	35	224
Net cash used in operating activities	(11,036)	(13,729)
Cash Flows From Investing Activities:
Purchase of short-term investments	(23,119)	(30,014)
Proceeds from maturities of short-term investments	33,300	25,000
Capital expenditures for property and equipment	(201)	(811)
Payments for Other Deposits	(3)
Proceeds from long-term deposits		4
Net cash provided by (used in) investing activities	9,844	(6,511)
Cash Flows From Financing Activities:
Proceeds from exercise of warrants	0	12,048
Proceeds from exercise of stock options	83	1,678
Repayment of debt	0	(275)
Net cash provided by financing activities	83	13,451
Net (decrease) increase in cash and cash equivalents	(1,109)	(6,789)
Cash and cash equivalents, beginning of period	4,937	16,647
Cash and cash equivalents, end of period	3,828	9,858
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Change in unrealized gain on short-term investments	62	(2)
Right-of-use asset and liability recorded during period	260	(66)
Patents and Trademarks [Member]
Cash Flows From Investing Activities:
Purchase of intangible assets	(133)	(129)
Intangibles Other than Patents and Trademarks [Member]
Cash Flows From Investing Activities:
Purchase of intangible assets	$ 0	$ (561)

Note 1 - Organization and Summa

Note 1 - Organization and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization and Business Description Wrap Technologies, Inc., a Delaware corporation (the “ Company we us our Common Stock Nasdaq Basis of Presentation The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“ SEC U.S. GAAP Annual Report Where necessary, the prior year’s information has been reclassified to conform to the current year presentation. Principles of Consolidation The Company has one VR Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates. Loss per Share Basic loss per common share is computed by dividing net loss for the period by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net loss per Common Share reflects the potential dilution of securities that could share in the earnings of an entity. The Company’s losses for the periods presented cause the inclusion of potential Common Stock instruments outstanding to be antidilutive. Stock options and restricted stock units exercisable or issuable for a total of 6,396,277 shares of Common Stock were outstanding at September 30, 2022. These securities are not included in the computation of diluted net loss per common share for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company. Recent Issued Accounting Guidance In October 2021 , FASB ASU Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ASU 2021-08 ASC , Revenue from Contracts with Customers Topic 606 , The Company has reviewed other recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations.

Note 2 - Revenue and Product Co

Note 2 - Revenue and Product Costs	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	2. REVENUE AND PRODUCT COSTS On January 1, 2018, the Company adopted Topic 606 and, as it had no prior revenue or contracts with customers, there was no transition required nor any impact on prior results. Topic 606 requires entities to recognize revenue through the application of a five-step model, which includes identification of the contract, identification of the performance obligations, determination of the transaction price, allocation of the transaction price to the performance obligations and recognition of revenue as the entity satisfies the performance obligations. The Company enters into contracts that include various combinations of products, accessories, software and services, each of which are generally distinct and are accounted for as separate performance obligations. Product sales includes BolaWrap products and accessories. Other revenue includes VR revenues, service, training and shipping revenues. A performance obligation is a promise in a contract to transfer a distinct good or service to a customer and is the unit of account in Topic 606 . SSP SSPs Most of the Company’s products and accessories are sold through domestic and international distributors. Performance obligations to deliver products and accessories are generally satisfied at the point in time the Company ships the product, as this is when the customer obtains control of the asset under our standard terms and conditions. Periodically, certain customers request bill and hold transactions for future delivery as scheduled and designated by them. In such cases, revenue is not recognized until after control, title and risk of ownership has transferred which is generally when the customer has requested such transaction under normal billing and payment terms and has been notified that the product (i) has been completed according to customer specifications, (ii) has passed quality control inspections, and (iii) has been tagged and packed for shipment, separated from other inventory and ready for physical transfer to the customer. The value associated with custodial storage services is deemed immaterial in the context of such contracts and in total, and accordingly, none of the transaction price is allocated to such service. The Company has elected to recognize shipping costs as an expense in cost of revenue when control has transferred to the customer. Time-based VR system contracts generally include setup, training and the use of software and hardware for a fixed term, generally one to five years and support and upgrade services during the same period. The Company does not sell time-based arrangements without setup, training and support services and therefore revenues for the entire arrangement are recognized on a straight-line basis over the term. When hardware is bundled and not sold separately the Company allocates the contract transaction price to each performance obligation using the SSP of each distinct good and service in the contract. The timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally has an unconditional right to consideration when customers are invoiced, and a receivable is recorded. A contract asset is recognized when revenue is recognized prior to invoicing, or a contract liability (deferred revenue) when revenue will be recognized subsequent to invoicing. The Company may receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below details the activity in our contract liabilities during the nine months ended September 30, 2022. Customer Deferred Deposits Revenue Balance at January 1, 2022 $ 43 $ 265 Additions, net - 171 Transfer to revenue (43 ) (136 ) Balance at September 30, 2022 $ - $ 300 Current portion $ - $ 144 Long-term portion $ - $ 156 At September 30, 2022, the Company’s deferred revenue of $300 consisted of $177 related to VR training and $123 related to BolaWrap extended warranties and services. At December 31, 2021, the Company’s deferred revenue of $265 consisted of $172 related to VR training and $67 related to extended warranties and services. The Company recognizes an asset if there are incremental costs of obtaining a contract with a customer such as commissions. These costs are ascribed to or allocated to the underlying performance obligations in the contract and amortized consistent with the recognition timing of the revenue for any such underlying performance obligations. The Company had no . Estimated costs for the Company’s standard warranty, generally one-year, are charged to cost of products sold when revenue is recorded for the related product. Royalties are also charged to cost of products sold.

Note 3 - Fair Value Measurement

Note 3 - Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Fair Value Disclosures [Text Block]	3. FAIR VALUE MEASUREMENTS Assets and liabilities recorded at fair value on a recurring basis in the Condensed Consolidated Balance Sheets and assets and liabilities measured at fair value on a non-recurring basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows: Level 1 Level 2 Level 3 The Company’s cash equivalent Money Market Funds and short-term investments consisting of U.S. Treasury bill securities are classified as Level I because they are valued using quoted market prices. The following table shows the Company’s cash and cash equivalents, Money Market Funds and short-term investments by significant investment category as of September 30, 2022, and December 31, 2021. As of September 30, 2022 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 3,382 $ - $ - $ 3,382 U.S. Treasury securities in short-term investments 19,803 62 - 19,865 Total Financial Assets $ 23,185 $ 62 $ - $ 23,247 As of December 31, 2021 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 1,670 $ - $ - $ 1,670 U.S. Treasury securities in short-term investments 29,989 - (6 ) 29,983 Total Financial Assets $ 31,659 $ - $ (6 ) $ 31,653 Unrealized gains or losses resulting from our short-term investments are recorded in accumulated other comprehensive gain or loss. During the three and nine months ended September 30, 2022, a $73 gain and $62 gain was recorded to accumulated other comprehensive gain (loss), respectively. During the three and nine months ended September 30, 2021, a $2 loss and a $4 loss was recorded to accumulated other comprehensive loss, respectively Our financial instruments also include accounts receivable, accounts payable, accrued liabilities and business acquisition liabilities. Due to the short-term nature of these instruments, their fair values approximate their carrying values on the balance sheet.

Note 4 - Inventories, Net

Note 4 - Inventories, Net	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Inventory Disclosure [Text Block]	4. INVENTORIES, NET Inventory is recorded at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. Inventories consisted of the following: September 30, December 31, 2022 2021 Finished goods $ 1,974 $ 1,027 Work in process - 2 Raw materials 988 537 Inventories, net $ 2,962 $ 1,566

Note 5 - Property and Equipment

Note 5 - Property and Equipment, Net	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	5. PROPERTY AND EQUIPMENT, NET Property and equipment consisted of the following: September 30, December 31, 2022 2021 Production and lab equipment $ 500 $ 500 Tooling 424 273 Computer equipment 513 467 Furniture, fixtures and improvements 181 176 1,618 1,416 Accumulated depreciation (799 ) (440 ) Property and equipment, net $ 819 $ 976 Depreciation expense was $121 and $359 for the three and nine months ended September 30, 2022 and was $69 and $191 for the three and nine months ended September 30, 2021, respectively.

Note 6 - Intangible Assets, Net

Note 6 - Intangible Assets, Net	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	6. INTANGIBLE ASSETS, NET Intangible assets consisted of the following: September 30, December 31, 2022 2021 Amortizable intangible assets: Patents $ 540 $ 416 Trademarks 143 134 Purchased software 1,212 1,212 Other 50 50 1,945 1,812 Accumulated amortization (389 ) (174 ) Total amortizable 1,556 1,638 Indefinite life assets (non-amortizable) 344 344 Total intangible assets, net $ 1,900 $ 1,982 Amortization expense was $72 and $215 for the three and nine months ended September 30, 2022 and was $48 and $145 for the three and nine months ended September 30, 2021, respectively. At September 30, 2022, future amortization expense is as follows: 2022 (3 months) $ 72 2023 284 2024 284 2025 280 2026 192 Thereafter 444 Total estimated amortization expense $ 1,556

Note 7 - Accounts Payable and A

Note 7 - Accounts Payable and Accrued Liabilities	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	7. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payable includes $61 and $228 due to related party Syzygy Licensing, LLC (“ Syzygy Accrued liabilities consist of the following: September 30, December 31, 2022 2021 Patent and legal costs $ 131 $ 28 Accrued compensation 759 628 Warranty costs 88 96 Taxes and other 13 72 $ 991 $ 824 Accrued compensation includes $25 of future severance payments for the Company’s former Chief Executive Officer payable through October 2022. Changes in our estimated product warranty costs were as follows: Nine months Ended September 30, 2022 2021 Balance, beginning of period $ 96 $ 48 Warranty settlements (63 ) (16 ) Warranty provision 55 42 Balance, end of period $ 88 $ 74

Note 8 - Lease

Note 8 - Lease	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	8. LEASES The Company determines if an arrangement is a lease at inception. The guidance in FASB ASC Topic 842, Leases ( ROU For leases beginning on or after January 1, 2019 , Amortization of ROU operating lease assets was $26 and $75 for the three and nine months ended September 30, 2022 and was $21 and $67 for the three and nine months ended September 30, 2021, respectively. Operating lease expense for capitalized operating leases included in operating activities was $30 and $88 for the three and nine months ended September 30, 2022 and was $23 and $73 for the three and nine months ended September 30, 2021, respectively. Operating lease obligations recorded on the balance sheet at September 30, 2022, are: Operating lease liability- short term $ 106 Operating lease liability - long term 221 Total Operating Lease Liability $ 327 Future lease payments included in the measurement of lease liabilities on the balance sheet at September 30, 2022, for future periods are as follows: 2022 (3 months) $ 31 2023 121 2024 125 2025 75 Total future minimum lease payments 352 Less imputed interest (25 ) Total $ 327 The weighted average remaining lease term is 2.83 years, and the weighted average discount rate is 5.0%. The Company had $3 and $0 short-term lease expense during the nine months ended September 30, 2022, and 2021. The Company does not have any finance leases.

Note 9 - Stockholders' Equity

Note 9 - Stockholders' Equity	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	9. STOCKHOLDERS' EQUITY The Company’s authorized capital consists of 150,000,000 shares of Common Stock, par value $0.0001 per share, and 5,000,000 shares of preferred stock, par value $0.0001 per share (“ Preferred Stock At December 31, 2021 the Company had outstanding Common Stock purchase warrants exercisable for 1,391,667 shares that expired on June 1, 2022, and had no purchase warrants outstanding at September 30, 2022.

Note 10 - Share-based Compensat

Note 10 - Share-based Compensation	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	10. SHARE-BASED COMPENSATION On March 31, 2017 , Plan , The Company generally recognizes share-based compensation expense on the grant date and over the period of vesting or period that services will be provided. In January 2022 the Company recognized severance acceleration of $242 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer as part of a management transition plan. Stock Options The following table summarizes stock option activity for the nine months ended September 30, 2022: Weighted Average Options on Remaining Aggregate Common Exercise Contractual Intrinsic Shares Price Term Value Outstanding January 1, 2022 3,935,883 $ 5.24 4.79 Granted 2,734,639 $ 2.85 Exercised (55,500 ) $ 1.50 Forfeited, cancelled, expired (978,709 ) $ 5.48 Outstanding September 30, 2022 5,636,313 $ 3.74 6.01 $ 232,778 Exercisable September 30, 2022 2,507,744 $ 4.47 2.14 $ 232,778 At September 30, 2022, there were 4,022,083 service-based stock options outstanding, and 1,614,230 performance-based stock options outstanding, which performance-based stock options were granted in April 2022 to the Company’s Chief Executive Officer and President, subject to future market capitalization targets. 1,049,145 of the 4,013,885 stock options granted included in the table above were granted in April 2022 outside the Plan as an employment inducement grant, but are subject to the terms and conditions of the Plan. The Company uses the Black-Scholes option pricing model to determine the fair value of service-based options granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees: For the Nine months Ended September 30, 2022 2021 Expected stock price volatility 49 % 50 % Risk-free interest rate 1.17 % 0.90 % Expected dividend yield 0 % 0 % Expected life of options - years 3.46 5.74 Weighted-average fair value of options granted $ 1.25 $ 2.57 Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of awards. The Company’s estimated volatility was based on an average of the historical volatility of peer entities whose stock prices were publicly available. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price. The Company records forfeitures as they are incurred. The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options. The dividend yield of zero The Company used the Monte Carlo Simulation Model to value at the grant date the aggregate of 1,614,230 market condition performance options granted in April 2022 to the Company’s newly appointed Chief Executive Officer and a newly appointed President. The assumptions used in the Monte Carlo Simulation were stock price on date of grant of $2.89, contract term of 10 years, expected volatility of 49% and risk-free interest rate of 2.9%. Vesting is based on sustained market capitalization of $250 million, $500 million and $1 billion and resulted in implied service periods ranging from approximately 4 to 7 years. Stock option expense was $308 and $1,448 for the three and nine months ended September 30, 2022 and was $ 1.302 Restricted Stock Units The Plan provides for the grant of restricted stock units (“ RSUs Weighted Average Weighted Average Service-Based Grant Date Vesting RSU's Fair Value Period (Years) Unvested at January 1, 2022 269,303 $ 6.47 Granted - service based 753,817 $ 2.57 Vested (218,133 ) $ 4.93 Forfeited and cancelled (60,023 ) $ 6.57 Unvested at September 30, 2022 744,964 $ 2.97 2.32 A total of 175,173 RSUs included in the table above were granted in April 2022 outside the Plan as an employment inducement grant but are subject to the terms and conditions of the Plan. RSU expense was $564 and $1,180 for the three and nine months ended September 30, 2022 and was $467 and $2,245 for the three and nine months ended September 30, 2021, respectively. Share-Based Compensation Expense The Company recorded share-based compensation for options and RSUs in its statements of operations for the relevant periods as follows: Three Months Ended September 30, Nine months Ended September 30, 2022 2021 2022 2021 Selling, general and administrative $ 700 $ 1,093 $ 2,180 $ 3,722 Research and development 172 210 448 588 Total share-based expense $ 872 $ 1,303 $ 2,628 $ 4,310 As of September 30, 2022, total estimated compensation expense of stock options granted and outstanding but not yet vested was $3,820 which is expected to be recognized over the weighted average period of 3.5 years. As of September 30, 2022, total estimated compensation cost of RSUs granted and outstanding but not yet vested was $1,828 which is expected to be recognized over the weighted average period of 2.3 years.

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	11. COMMITMENTS AND CONTINGENCIES Facility Lease See Note 8. Related Party Technology License Agreement The Company is obligated to pay royalties and development and patent costs pursuant to an exclusive Amended and Restated Intellectual Property License Agreement dated as of September 30, 2016, with Syzygy, a company owned and controlled by stockholder/consultant Mr. Elwood Norris and stockholder/consultant Mr. James Barnes. The agreement provides for royalty payments of 4% of revenue from products employing the licensed ensnarement device technology up to an aggregate of $1,000 in royalties or until September 30, 2026 , Purchase Commitments At September 30, 2022, the Company was committed for approximately $4,376 for future component deliveries that are generally subject to modification or rescheduling in the normal course of business.

Note 12 - Related Party Transac

Note 12 - Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	12. RELATED PARTY TRANSACTIONS Commencing in October 2017 the Company began reimbursing Mr. Elwood Norris, a former officer and current stockholder and consultant of the Company, $1.5 per month on a month-to-month basis for laboratory facility expense, for an aggregate of $13.5 during the nine months ended September 30, 2022, and 2021, respectively. See Notes 7, 10 and 11 for additional information on related party transactions and obligations.

Note 13 - Major Customers and R

Note 13 - Major Customers and Related Information	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	13. MAJOR CUSTOMERS AND RELATED INFORMATION For the three months ended September 30, 2022, revenues from one two For the nine months ended September 30, 2022, revenues from one two At September 30, 2022, accounts receivable from two Three The following table summarizes revenues by geographic region. Revenues are attributed to countries based on customer’s delivery location: For the Three Months For the Nine months Ended September 30, Ended September 30, 2022 2021 2022 2021 Americas $ 1,478 $ 1,088 $ 3,484 $ 2,837 Europe, Middle East and Africa 220 745 435 2,424 Asia Pacific 3 (28 ) 545 19 Total revenues $ 1,701 $ 1,805 $ 4,464 $ 5,280

Note 14 - Subsequent Events

Note 14 - Subsequent Events	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Subsequent Events [Text Block]	14. SUBSEQUENT EVENTS On October 11, 2022, the company received an order from an international government agency for the purchase of over 2,000 BolaWrap devices, cassettes and other accessories totaling over $1.5 million. This order will be recorded in the fourth quarter 2022. The Company evaluated subsequent events for their potential impact on the financial statements and disclosures through the date the financial statements were available to be issued, and determined that, except as disclosed herein, no subsequent events occurred that were reasonably expected to impact the financial statements presented herein.

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Organization and Business Description [Policy Text Block]	Organization and Business Description Company we us our Common Stock Nasdaq
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation SEC U.S. GAAP Annual Report
Consolidation, Policy [Policy Text Block]	Principles of Consolidation one VR
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
Earnings Per Share, Policy [Policy Text Block]	Loss per Share
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Issued Accounting Guidance , FASB ASU Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ASU 2021-08 ASC , Revenue from Contracts with Customers Topic 606 ,

Note 2 - Revenue and Product _2

Note 2 - Revenue and Product Costs (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	Customer Deferred Deposits Revenue Balance at January 1, 2022 $ 43 $ 265 Additions, net - 171 Transfer to revenue (43 ) (136 ) Balance at September 30, 2022 $ - $ 300 Current portion $ - $ 144 Long-term portion $ - $ 156

Note 3 - Fair Value Measureme_2

Note 3 - Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	As of September 30, 2022 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 3,382 $ - $ - $ 3,382 U.S. Treasury securities in short-term investments 19,803 62 - 19,865 Total Financial Assets $ 23,185 $ 62 $ - $ 23,247 As of December 31, 2021 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 1,670 $ - $ - $ 1,670 U.S. Treasury securities in short-term investments 29,989 - (6 ) 29,983 Total Financial Assets $ 31,659 $ - $ (6 ) $ 31,653

Note 4 - Inventories, Net (Tabl

Note 4 - Inventories, Net (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Inventory, Current [Table Text Block]	September 30, December 31, 2022 2021 Finished goods $ 1,974 $ 1,027 Work in process - 2 Raw materials 988 537 Inventories, net $ 2,962 $ 1,566

Note 5 - Property and Equipme_2

Note 5 - Property and Equipment, Net (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	September 30, December 31, 2022 2021 Production and lab equipment $ 500 $ 500 Tooling 424 273 Computer equipment 513 467 Furniture, fixtures and improvements 181 176 1,618 1,416 Accumulated depreciation (799 ) (440 ) Property and equipment, net $ 819 $ 976

Note 6 - Intangible Assets, N_2

Note 6 - Intangible Assets, Net (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	September 30, December 31, 2022 2021 Amortizable intangible assets: Patents $ 540 $ 416 Trademarks 143 134 Purchased software 1,212 1,212 Other 50 50 1,945 1,812 Accumulated amortization (389 ) (174 ) Total amortizable 1,556 1,638 Indefinite life assets (non-amortizable) 344 344 Total intangible assets, net $ 1,900 $ 1,982
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2022 (3 months) $ 72 2023 284 2024 284 2025 280 2026 192 Thereafter 444 Total estimated amortization expense $ 1,556

Note 7 - Accounts Payable and_2

Note 7 - Accounts Payable and Accrued Liabilities (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Accrued Liabilities [Table Text Block]	September 30, December 31, 2022 2021 Patent and legal costs $ 131 $ 28 Accrued compensation 759 628 Warranty costs 88 96 Taxes and other 13 72 $ 991 $ 824
Schedule of Product Warranty Liability [Table Text Block]	Nine months Ended September 30, 2022 2021 Balance, beginning of period $ 96 $ 48 Warranty settlements (63 ) (16 ) Warranty provision 55 42 Balance, end of period $ 88 $ 74

Note 8 - Lease (Tables)

Note 8 - Lease (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Lessee, Operating Lease, Disclosure [Table Text Block]	Operating lease liability- short term $ 106 Operating lease liability - long term 221 Total Operating Lease Liability $ 327
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	2022 (3 months) $ 31 2023 121 2024 125 2025 75 Total future minimum lease payments 352 Less imputed interest (25 ) Total $ 327

Note 10 - Share-based Compens_2

Note 10 - Share-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Weighted Average Options on Remaining Aggregate Common Exercise Contractual Intrinsic Shares Price Term Value Outstanding January 1, 2022 3,935,883 $ 5.24 4.79 Granted 2,734,639 $ 2.85 Exercised (55,500 ) $ 1.50 Forfeited, cancelled, expired (978,709 ) $ 5.48 Outstanding September 30, 2022 5,636,313 $ 3.74 6.01 $ 232,778 Exercisable September 30, 2022 2,507,744 $ 4.47 2.14 $ 232,778
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	For the Nine months Ended September 30, 2022 2021 Expected stock price volatility 49 % 50 % Risk-free interest rate 1.17 % 0.90 % Expected dividend yield 0 % 0 % Expected life of options - years 3.46 5.74 Weighted-average fair value of options granted $ 1.25 $ 2.57
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	Weighted Average Weighted Average Service-Based Grant Date Vesting RSU's Fair Value Period (Years) Unvested at January 1, 2022 269,303 $ 6.47 Granted - service based 753,817 $ 2.57 Vested (218,133 ) $ 4.93 Forfeited and cancelled (60,023 ) $ 6.57 Unvested at September 30, 2022 744,964 $ 2.97 2.32
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]	Three Months Ended September 30, Nine months Ended September 30, 2022 2021 2022 2021 Selling, general and administrative $ 700 $ 1,093 $ 2,180 $ 3,722 Research and development 172 210 448 588 Total share-based expense $ 872 $ 1,303 $ 2,628 $ 4,310

Note 13 - Major Customers and_2

Note 13 - Major Customers and Related Information (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Disaggregation of Revenue [Table Text Block]	For the Three Months For the Nine months Ended September 30, Ended September 30, 2022 2021 2022 2021 Americas $ 1,478 $ 1,088 $ 3,484 $ 2,837 Europe, Middle East and Africa 220 745 435 2,424 Asia Pacific 3 (28 ) 545 19 Total revenues $ 1,701 $ 1,805 $ 4,464 $ 5,280

Note 1 - Organization and Sum_2

Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)	9 Months Ended
	Sep. 30, 2022 $ / shares shares	Dec. 31, 2021 $ / shares
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001	$ 0.0001
Number of Wholly-owned Subsidiaries	1
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares	6,396,277

Note 2 - Revenue and Product _3

Note 2 - Revenue and Product Costs (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Contract with Customer, Liability, Total	$ 300	$ 265
Contract with Customer, Asset, after Allowance for Credit Loss, Total	0	0
Virtual Reality Training [Member]
Contract with Customer, Liability, Total	177	172
Extended Product Warranties [Member]
Contract with Customer, Liability, Total	$ 123	$ 67

Note 2 - Revenue and Product _4

Note 2 - Revenue and Product Costs - Contract Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Balance at January 1, 2022	$ 265
Balance at June 30, 2022	300
Current portion	144	$ 155
Long-term portion	156	$ 110
Customer Deposits [Member]
Balance at January 1, 2022	43
Additions, net	0
Transfer to revenue	(43)
Balance at June 30, 2022	0
Current portion	0
Long-term portion	0
Deferred Revenue [Member]
Balance at January 1, 2022	265
Additions, net	171
Transfer to revenue	(136)
Balance at June 30, 2022	300
Current portion	144
Long-term portion	$ 156

Note 3 - Fair Value Measureme_3

Note 3 - Fair Value Measurements (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	$ 73	$ (2)	$ 62	$ (4)

Note 3 - Fair Value Measureme_4

Note 3 - Fair Value Measurements - Instruments by Significant Investment Category (Details) - Fair Value, Inputs, Level 1 [Member] - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Adjusted Cost	$ 23,185	$ 31,659
Unrealized Gains	62	0
Unrealized Losses	0	(6)
Market Value	23,247	31,653
Money Market Fund [Member]
Adjusted Cost	3,382	1,670
Unrealized Gains	0	0
Unrealized Losses	0	0
Market Value	3,382	1,670
US Treasury Securities in Short-term Investments [Member]
Adjusted Cost	19,803	29,989
Unrealized Gains	62	0
Unrealized Losses	0	(6)
Market Value	$ 19,865	$ 29,983

Note 4 - Inventories, Net - Sum

Note 4 - Inventories, Net - Summary of Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Finished goods	$ 1,974	$ 1,027
Work in process	0	2
Raw materials	988	537
Inventories, net	$ 2,962	$ 1,566

Note 5 - Property and Equipme_3

Note 5 - Property and Equipment, Net (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Depreciation, Total	$ 121	$ 69	$ 359	$ 191

Note 5 - Property and Equipme_4

Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Property and equipment, gross	$ 1,618	$ 1,416
Accumulated depreciation	(799)	(440)
Property and equipment, net	819	976
Production and Lab Equipment [Member]
Property and equipment, gross	500	500
Tooling [Member]
Property and equipment, gross	424	273
Computer Equipment [Member]
Property and equipment, gross	513	467
Furniture and Fixtures [Member]
Property and equipment, gross	$ 181	$ 176

Note 6 - Intangible Assets, N_3

Note 6 - Intangible Assets, Net (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Amortization of Intangible Assets	$ 72	$ 48	$ 215	$ 145

Note 6 - Intangible Assets, N_4

Note 6 - Intangible Assets, Net - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Amortizable intangible assets, gross	$ 1,945	$ 1,812
Accumulated amortization	(389)	(174)
Total amortizable	1,556	1,638
Indefinite life assets (non-amortizable)	344	344
Total intangible assets, net	1,900	1,982
Patents [Member]
Amortizable intangible assets, gross	540	416
Trademarks [Member]
Amortizable intangible assets, gross	143	134
Computer Software, Intangible Asset [Member]
Amortizable intangible assets, gross	1,212	1,212
Other Intangible Assets [Member]
Amortizable intangible assets, gross	$ 50	$ 50

Note 6 - Intangible Assets, N_5

Note 6 - Intangible Assets, Net - Future Amortization Expense (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
2022 (3 months)	$ 72
2023	284
2024	284
2025	280
2026	192
Thereafter	444
Total amortizable	$ 1,556	$ 1,638

Note 7 - Accounts Payable and_3

Note 7 - Accounts Payable and Accrued Liabilities (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Former CEO Payable [Member]
Employee-related Liabilities, Total	$ 25
Syzygy Licensing LLC [Member]
Accounts Payable, Total	$ 61	$ 228

Note 7 - Accounts Payable and_4

Note 7 - Accounts Payable and Accrued Liabilities - Summary of Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Patent and legal costs	$ 131	$ 28
Accrued compensation	759	628
Warranty costs	88	96
Taxes and other	13	72
Accrued Liabilities, Current, Total	$ 991	$ 824

Note 7 - Accounts Payable and_5

Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Balance, beginning of period	$ 96	$ 48
Warranty settlements	(63)	(16)
Warranty provision	55	42
Balance, end of period	$ 88	$ 74

Note 8 - Lease (Details Textual

Note 8 - Lease (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating Lease, Right-of-Use Asset, Amortization Expense	$ 26,000	$ 21,000	$ 75,000	$ 67,000
Operating Lease, Expense	$ 30,000	$ 23,000	$ 88,000	73,000
Operating Lease, Weighted Average Remaining Lease Term	2 years 9 months 29 days		2 years 9 months 29 days
Operating Lease, Weighted Average Discount Rate, Percent	5%		5%
Short-Term Lease, Cost			$ 3	$ 0

Note 8 - Lease - Summary of Ope

Note 8 - Lease - Summary of Operating Lease Obligations (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Operating lease liability - short term	$ 106	$ 56
Operating lease liability - long term	221	$ 0
Total Operating Lease Liability	$ 327

Note 8 - Lease - Future Lease P

Note 8 - Lease - Future Lease Payments (Details) $ in Thousands	Sep. 30, 2022 USD ($)
2022 (3 months)	$ 31
2023	121
2024	125
2025	75
Total future minimum lease payments	352
Less imputed interest	(25)
Total	$ 327

Note 9 - Stockholders' Equity (

Note 9 - Stockholders' Equity (Details Textual) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Common Stock, Shares Authorized	150,000,000	150,000,000
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Class of Warrant or Right, Outstanding		1,391,667

Note 10 - Share-based Compens_3

Note 10 - Share-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended						3 Months Ended		9 Months Ended
	Jun. 30, 2022	Apr. 30, 2022	Jan. 31, 2022	Jun. 30, 2021	Jun. 30, 2020	May 31, 2019	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Mar. 31, 2017
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance							5,636,313		5,636,313		3,935,883
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross									2,734,639
Share-Based Payment Arrangement, Expense							$ 872	$ 1,303	$ 2,628	$ 4,310
Employment Inducement Grant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross		1,049,145
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate									0%	0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term									3 years 5 months 15 days	5 years 8 months 26 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate									49%	50%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate									1.17%	0.90%
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount							3,820		$ 3,820
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition									3 years 6 months
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period		175,173							753,817
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount							$ 1,828		$ 1,828
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition									2 years 3 months 18 days
The 2017 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized	9,000,000											2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized	1,500,000			1,500,000	1,900,000	2,100,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant							1,624,160		1,624,160
Share-Based Payment Arrangement, Accelerated Cost			$ 242
The 2017 Stock Incentive Plan [Member] | Service-based Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance							4,022,083		4,022,083
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross		1,614,230
Share Price		$ 2.89
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term		10 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate		49%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		2.90%
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period		4 years
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period		7 years
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization		$ 250,000
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization		500,000
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization		$ 1,000,000
The 2017 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Expense							$ 308	1,302	$ 1,448	$ 4,310
The 2017 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Expense							$ 564	$ 467	$ 1,180	$ 2,245

Note 10 - Share-based Compens_4

Note 10 - Share-based Compensation - Summary of Stock Option Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 $ / shares shares
Options on Common Shares, Outstanding (in shares) | shares	3,935,883
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 5.24
Outstanding, remaining contractual term (Year)	6 years 3 days	4 years 9 months 14 days
Options on Common Shares, Granted (in shares) | shares	2,734,639
Granted, weighted average exercise price (in dollars per share) | $ / shares	$ 2.85
Options on Common Shares, Exercised (in shares) | shares	(55,500)
Exercised, weighted average exercise price (in dollars per share) | $ / shares	$ 1.50
Options on Common Shares, Forfeited, cancelled, expired (in shares) | shares	(978,709)
Forfeited, cancelled, expired, weighted average exercise price (in dollars per share) | $ / shares	$ 5.48
Outstanding September 30, 2022 (in shares) | shares	5,636,313	3,935,883
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 3.74	$ 5.24
Outstanding September 30, 2022 | $	$ 232,778
Exercisable September 30, 2022 (in shares) | shares	2,507,744
Exercisable weighted average exercise price (in dollars per share) | $ / shares	$ 4.47
Exercisable, remaining contractual term (Year)	2 years 1 month 20 days
Exercisable September 30, 2022 | $	$ 232,778

Note 10 - Share-based Compens_5

Note 10 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details) - $ / shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Weighted-average fair value of options granted (in dollars per share)	$ 1.25	$ 2.57
Share-Based Payment Arrangement, Option [Member]
Expected stock price volatility	49%	50%
Risk-free interest rate	1.17%	0.90%
Expected dividend yield	0%	0%
Expected life of options (Year)	3 years 5 months 15 days	5 years 8 months 26 days

Note 10 - Share-based Compens_6

Note 10 - Share-based Compensation - Summary of RSU Activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	1 Months Ended	9 Months Ended
	Apr. 30, 2022	Sep. 30, 2022
Awards other than options, unvested, beginning balance (in shares)		269,303
Awards other than options, unvested, weighted average grant date fair value, beginning balance (in dollars per share)		$ 6.47
Awards other than options, Granted (in shares)	175,173	753,817
Awards other than options, granted, weighted average grant date fair value (in dollars per share)		$ 2.57
Awards other than options, Vested (in shares)		(218,133)
Awards other than options, vested, weighted average grant date fair value (in dollars per share)		$ 4.93
Awards other than options, Forfeited and cancelled (in shares)		(60,023)
Awards other than options, forfeited and cancelled, weighted average grant date fair value (in dollars per share)		$ 6.57
Awards other than options, unvested, ending balance (in shares)		744,964
Awards other than options, unvested, weighted average grant date fair value, ending balance (in dollars per share)		$ 2.97
Weighted average vesting period (Year)		2 years 3 months 25 days

Note 10 - Share-based Compens_7

Note 10 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-based expense	$ 872	$ 1,303	$ 2,628	$ 4,310
Selling, General and Administrative Expenses [Member]
Share-based expense	700	1,093	2,180	3,722
Research and Development Expense [Member]
Share-based expense	$ 172	$ 210	$ 448	$ 588

Note 11 - Commitments and Con_2

Note 11 - Commitments and Contingencies (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2016
Contractual Obligation, Total	$ 4,376,000		$ 4,376,000
Related Party Technology License Agreement [Member] | Syzygy Licensing LLC [Member]
Royalty Payments, Percentage of Product Revenue					4%
Maximum Royalties to Be Paid Under Agreement					$ 1,000
Royalty Expense	$ 61,000	$ 65,000	$ 147,000	$ 185,000

Note 12 - Related Party Trans_2

Note 12 - Related Party Transactions (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Related Party Transaction, Amounts of Transaction	$ 13,500	$ 13,500
Mr. Elwood Norris [Member]
Reimbursement of Expenses to Related Party, Monthly Amount	$ 1,500

Note 13 - Major Customers and_3

Note 13 - Major Customers and Related Information (Details Textual) - Customer Concentration Risk [Member]	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenue Benchmark [Member] | Distributors [Member]
Number of Major Customers	1	2	1	2
Revenue Benchmark [Member] | Distributor One [Member]
Concentration Risk, Percentage	59%	41%	39%	27%
Revenue Benchmark [Member] | Distributor Two [Member]
Concentration Risk, Percentage		29%		21%
Accounts Receivable [Member] | Distributors [Member]
Number of Major Customers			2		3
Accounts Receivable [Member] | Distributor One [Member]
Concentration Risk, Percentage			42%		48%
Accounts Receivable [Member] | Distributor Two [Member]
Concentration Risk, Percentage			15%		16%
Accounts Receivable [Member] | Distributor Three [Member]
Concentration Risk, Percentage					15%

Note 13 - Major Customers and_4

Note 13 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues	$ 1,701	$ 1,805	$ 4,464	$ 5,280
Americas [Member]
Revenues	1,478	1,088	3,484	2,837
Europe, Middle East and Africa [Member]
Revenues	220	745	435	2,424
Asia Pacific [Member]
Revenues	$ 3	$ (28)	$ 545	$ 19

Note 14 - Subsequent Events (De

Note 14 - Subsequent Events (Details Textual) - USD ($) $ in Thousands	Oct. 11, 2022	Sep. 30, 2022	Dec. 31, 2021
Contract with Customer, Liability, Total		$ 300	$ 265
International Government Agency [Member] | Subsequent Event [Member]
Contract with Customer, Liability, Total	$ 1,500